Skip to main content
Clinical Trials/ACTRN12622000876796
ACTRN12622000876796
Recruiting
未知

Assessing the impact of high-intensity interval training on the pathophysiology causing obstructive sleep apnoea

Monash University0 sites24 target enrollmentJune 21, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Obstructive Sleep Apnoea
Sponsor
Monash University
Enrollment
24
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 21, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Moderate/severe OSA (10 \=\>AHI \<\= 50 events/hr)
  • \-Overweight (25 \>\= BMI \<\= 35 kg/m2\)
  • \-Engaged in less than or equal to 5 sessions of high intensity training within in the past 6 months
  • \-Physical activity levels have remained below the following in the past three months
  • \-\<150 minutes of moderate\-intensity activity or walking in a typical week; and
  • \-\<75 minutes of vigorous\-intensity activity in a typical week
  • \-At stable medication doses (for greater than 3 months)
  • \-Diagnosed with OSA and not currently using OSA treatment or are willing to abstain from using OSA treatment for the duration of the study.
  • \-Epworth Sleepiness Scale (ESS) greater than 16 at screening
  • \-Not actively trying to lose weight

Exclusion Criteria

  • \-Known or suspected significant cardiovascular, pulmonary, or metabolic disease
  • \-Uncontrolled hypertension (\>159/99 mm Hg)
  • \-Patients with safety concerns (drowsy driving within the past 2 years)
  • \-Receiving medication that could affect ventilation (i.e., morphine derivatives, benzodiazepines, theophylline) or muscle control.
  • \-Previous surgical treatment for OSA and/or obesity
  • \-Women who are pregnant or currently trying to become pregnant
  • \-Inability to exercise due to orthopaedic or musculoskeletal problems
  • \-Score below 2 on the STOP Bang Questionnaire
  • \-Allergy to any of the local anaesthetics used to insert the genioglossus intramuscular electrodes (e.g. Lidocaine, Lidocaine–Prilocaine). The local anaesthetic is used to reduce the the potential pain or discomfort caused by the insertion of the intramuscular electrodes during the polysomnography which is part of the assessment of study outcomes.

Outcomes

Primary Outcomes

Not specified

Similar Trials